Virtu Financial LLC Zentalis Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$4.09 - $16.13 $381,130 - $1.5 Million
93,186 New
93,186 $381,000
Q3 2023

Nov 14, 2023
BUY
$19.63 - $28.29 $318,457 - $458,948
16,223 New
16,223 $325,000
Q1 2021

May 19, 2021
SELL
$35.69 - $52.72 $254,897 - $376,526
-7,142 Closed
0 $0
Q4 2020

Feb 24, 2021
BUY
$31.71 - $57.97 $226,472 - $414,021
7,142 New
7,142 $371,000

Others Institutions Holding ZNTL

# of Institutions
142
Shares Held
67.9M
Call Options Held
48.5K
Put Options Held
89.6K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $170M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email